Is Shoe Zone PLC A Contrarian Buy After 25%+ Fall?

Shares in Shoe Zone PLC (LON:SHOE) are down by 28%, but has the sell-off been overdone?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Shares in AIM-listed budget shoe retailer Shoe Zone (LSE: SHOE) fell by 28% this morning, after the firm issued a profit warning and cut its planned dividend payout for the current year.

The firm blamed unseasonably warm winter weather for the slowdown in revenue growth, which it says was driven by customers choosing lower priced warm weather shoes, such as ladies ankle boots, rather than more highly priced winter offerings such as long boots.

Despite this disappointment, I reckon today’s sell-off could be overdone: Shoe Zone shares weren’t expensive to start with, and the firm’s finances remain strong.

Too vague

My biggest concern about today’s announcement was that it was so vague.

The firm said that “sales volumes increased” over the last six months, but that “average price was down”.

Margins remain “robust” and the net cash position is “strong”, but full year results are expected to be “below expectations” and the dividend will be “adjusted accordingly”.

Today’s statement did not contain a single number, making it very hard to estimate how far below expectations this year’s profits and dividend payment are likely to be. This makes buying at today’s prices a risk, but may also be the reason the shares have fallen so far.

A look at the numbers

Before today’s announcement, Shoe Zone’s house broker was forecasting earnings of 20.5p per share and a dividend of 12.3p per share for the firm’s current financial year, which ends in October.

I reckon that these forecasts will be cut by at least 10%, perhaps more. Assuming a reduction of 20% in both earnings per share and the dividend, here’s how things look with the shares at 183p:

20% cut to current 2015 forecasts

Values

Forecast P/E

11.2

Prospective yield

5.4%

Although this is only a guess, if accurate, Shoe Zone shares could now be quite attractively priced.

It’s worth remembering that the firm had net cash of £9.1m at the end of last year, and expects to end this year with net cash as well.

Not without risk

I believe Shoe Zone could be a profitable contrarian buy: if this year’s profit miss turns out not to be as bad as expected, the shares could rise sharply.

On the other hand, the old stock market adage that profit warnings come in threes is very often true, as management only gradually admit the scale of the problems they face.

If you’re tempted to buy today, I’d buy small, and wait for better news before acquiring more shares.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Roland Head has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Dividend Shares

A 12.65% yield? Here’s the dividend forecast for this FTSE income share

Jon Smith talks through the2026/27 dividend forecast for an income stock that already has a double-digit yield but could go…

Read more »

Young Asian woman holding a cup of takeaway coffee and folders containing paperwork, on her way into the office
Investing Articles

Down 23% last year, here’s a FTSE 100 share that could rebound (and then some) in 2025!

Royston Wild thinks this dirt cheap FTSE 100 share has the ingredients to bounce back after a tough few years.…

Read more »

Investing Articles

2 beaten-down shares to consider for a Stocks and Shares ISA in 2025

These high-quality businesses have suffered recent share price setbacks. This writer thinks they're now worth considering for a Stocks and…

Read more »

Fans of Warren Buffett taking his photo
Investing For Beginners

This billionaire is copying Warren Buffett. Should I do the same?

Jon Smith reviews fresh news about how an investment billionaire is imitating Warren Buffett as he goes after an interesting…

Read more »

Investing Articles

I expect these 3 FTSE 100 shares to fly when inflation really starts to fall

Harvey Jones picks out three FTSE 100 shares whose fortunes should improve once inflation is finally on the run. They're…

Read more »

Investing Articles

After a positive Q4 update, is the Vistry share price set to bounce back?

The Vistry share price has been falling sharply as a result of cost issues in its South Division. But the…

Read more »

Investing Articles

Is it game over for the Diageo share price?

The Diageo share price is showing as much spirit as an alcohol-free cocktail. Harvey Jones is wondering whether he should…

Read more »

Young Caucasian girl showing and pointing up with fingers number three against yellow background
Investing Articles

3 key reasons why AstraZeneca’s share price looks a steal to me right now

AstraZeneca’s share price has fallen a long way from its record-breaking level last year, which indicates that I may be…

Read more »